We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
-0.8%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$74.9B
AUM Growth
-$1.53B
(-2%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
34.07%
Holding
4,428
New
282
Increased
1,508
Reduced
1,702
Closed
242
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$460M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$251M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$92.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$82.3M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$549M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$415M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$56.6M |
| 4 |
Microsoft
MSFT
|
+$44.5M |
| 5 |
Apple
AAPL
|
+$35.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.72% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 6.69% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Staples | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Allogene Therapeutics
ALLO
$611M
| $10.2K | ﹤0.01% |
6,968
+6,229
| +843% | +$11.7K |
|
3427
Ribbon Communications
RBBN
$361M
| $10.1K | ﹤0.01% |
2,583
-1,130
| -30% | -$4.76K |
|
3428
Harbor Commodity All-Weather Strategy ETF
HGER
$3.78B
| $10.1K | ﹤0.01% |
+421
| New | +$9.79K |
|
|
MOFG
3429
DELISTED
MidWestOne Financial Group
MOFG
| $10.1K | ﹤0.01% |
340
-17
| -5% | -$513 |
|
3430
Alpha Metallurgical Resources
AMR
$1.84B
| $10K | ﹤0.01% |
80
-29
| -27% | -$4.72K |
|
|
AIOT
3431
PowerFleet Inc
AIOT
$513M
| $9.97K | ﹤0.01% |
1,817
-836
| -32% | -$5.36K |
|
3432
Vir Biotechnology
VIR
$1.5B
| $9.96K | ﹤0.01% |
1,537
+996
| +184% | +$8.86K |
|
|
ONTF
3433
DELISTED
ON24
ONTF
| $9.91K | ﹤0.01% |
1,906
-786
| -29% | -$4.88K |
|
3434
Recursion Pharmaceuticals
RXRX
$1.63B
| $9.9K | ﹤0.01% |
1,871
+163
| +10% | +$1.19K |
|
|
EFC
3435
Ellington Financial
EFC
$1.69B
| $9.85K | ﹤0.01% |
743
+334
| +82% | +$4.32K |
|
3436
MiMedx Group
MDXG
$651M
| $9.8K | ﹤0.01% |
1,290
-150
| -10% | -$1.25K |
|
3437
Braskem
BAK
$972M
| $9.77K | ﹤0.01% |
2,537
+2,149
| +554% | +$8.93K |
|
3438
Cardiff Oncology
CRDF
$65.4M
| $9.76K | ﹤0.01% |
3,109
| – | – |
|
3439
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$704M
| $9.76K | ﹤0.01% |
240
-100
| -29% | -$4.53K |
|
|
EB
3440
DELISTED
Eventbrite
EB
| $9.76K | ﹤0.01% |
4,623
-35,388
| -88% | -$106K |
|
3441
Daktronics
DAKT
$959M
| $9.74K | ﹤0.01% |
800
-125
| -14% | -$1.89K |
|
|
CVAC
3442
DELISTED
CureVac
CVAC
| $9.7K | ﹤0.01% |
3,501
+1,336
| +62% | +$4.65K |
|
3443
SkinHealth Systems
SKIN
$99.4M
| $9.64K | ﹤0.01% |
7,198
-2
| -0% | -$3 |
|
|
DQ
3444
Daqo New Energy
DQ
$809M
| $9.62K | ﹤0.01% |
531
-61
| -10% | -$1.19K |
|
3445
LCNB Corp
LCNB
$289M
| $9.61K | ﹤0.01% |
650
| – | – |
|
3446
iShares CMBS ETF
CMBS
$473M
| $9.6K | ﹤0.01% |
200
-10
| -5% | -$477 |
|
|
DMC
3447
Del Monte Corp
DMC
$1.36B
| $9.59K | ﹤0.01% |
311
| – | – |
|
3448
ePlus
PLUS
$2.34B
| $9.58K | ﹤0.01% |
157
+5
| +3% | +$354 |
|
3449
Outdoor Holding Co
POWW
$252M
| $9.52K | ﹤0.01% |
+6,900
| New | +$10.7K |
|
|
MFA
3450
MFA Financial
MFA
$934M
| $9.49K | ﹤0.01% |
925
+194
| +27% | +$2.03K |
|
Similar funds
US Bancorp's Q1 2025 Portfolio in Review
As of Q1 2025, US Bancorp held 4,428 positions worth $74.9B, down 2% from $76.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
US Bancorp's Q1 2025 filing shows 282 new, 1,508 increased, 1,702 reduced and 242 closed positions. Its largest new stake was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M. The largest sale was Eli Lilly, an estimated $549M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- US Bancorp's largest Q1 2025 buy was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M.
- US Bancorp added most to Vanguard Total International Stock ETF in Q1 2025, an estimated $460M increase.
- US Bancorp's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $549M.
- US Bancorp fully exited Aspen Technology Inc in Q1 2025, selling an estimated $3.17M.
- US Bancorp's ten largest holdings make up 34% of its $74.9B portfolio in Q1 2025.
- US Bancorp opened 282 new positions and closed 242 in Q1 2025.
- US Bancorp's portfolio value fell 2% quarter-over-quarter to $74.9B.
Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.